DRMA · Dermata Therapeutics

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

3525 Del Mar Heights Rd., San Diego, CA, 92130, United States
Biotechnology
Healthcare

Market Cap

5.599M

52 Wk Range

$0.95 - $5.87

Previous Close

$1.13

Open

$1.10

Volume

15,145

Day Range

$1.10 - $1.12

Enterprise Value

1.137M

Cash

4.413M

Avg Qtr Burn

-2.422M

Insider Ownership

27.35%

Institutional Own.

7.77%

Qtr Updated

Jun 30th 2026